[Client Snapshot] DKSH Korea Healthcare Division Holds Its First Press Conference
등록일 26-08-20
DKSH Korea Healthcare Division Holds Its First Press Conference
HSMC joined DKSH Korea's Healthcare Division for its first official press conference since launching operations in Korea, held with formally invited media.
The press conference marked the expansion of health insurance coverage for Romiplate as a first-line treatment for severe aplastic anemia, and introduced the clinical significance of this change for Korea's treatment landscape and patient benefits, along with DKSH Korea Healthcare Division's future business strategy.
Representatives from wire services, daily and business newspapers, and trade publications attended, reflecting strong media interest in the announcement.
Beyond distribution, DKSH Korea's Healthcare Division supports the full scope of pharmaceutical business operations for global pharmaceutical companies in Korea — including regulatory approval, market entry strategy, pricing and reimbursement, and sales and marketing.
Through this press conference, the division took the opportunity to highlight its role as a specialized partner connecting innovative global therapies with patients in Korea and expanding access to treatment.
HSMC will continue to provide ongoing PR communications support to strengthen DKSH Korea Healthcare Division's expertise and market influence.
